ACCED, The Medication Safety Robot that Has Dominated the French Market for Ten Years, Continues Its Record-Breaking Commercial Expansion
Deenova, Europe's leading provider of hospital pharmacy automation unit dose medication solutions, announced today the award of two competitive UniHA tender in France for three of its market-leading solution ACCED, with Drôme Vivarais hospital in Montéléger and St-Marcellin hospital.
The ACCED mechatronics solution, which is already in use in over 60 French hospitals, is a fully automated system that allows for the preparation and dispensing of oral solid medications in unit dose. It is intended to improve patient safety, reduce medication errors, and maximize operational efficiency while providing secure and dependable medication preparation and dispensing processes. Furthermore, the solution includes a reporting and analytics platform that provides hospitals with data-driven insights to improve operational performance.
Commenting on the news, Mr. Loic Bessin, Managing Director of Deenova France, said: "We are thrilled to be extending our automated unit dose medication solutions to Drôme Vivarais and St-Marcellin hospitals in France. Our D3 ACCED mechatronic robot is designed specifically to ensure complete patient safety, operational effectiveness, and financial viability. We are confident that both hospitals and their patients will benefit greatly from our solution. "
The St-Marcellin Hospital is a healthcare institution that provides a public service mission of care and accommodation, combining proximity and a recognized level of technicality in the activities of medicine, rehabilitation care and elderly care.
Opened in 1976, the Centre Hospitalier Drôme Vivarais (formerly known as the "Centre Hospitalier Le Valmont") is a public health establishment specialising in child and adult psychiatry, located in the commune of Montéléger, just a few kilometres from Valence.
It manages 240 beds on a hospitalization site, 11 Day Hospitals and 17 Medical-Psychological Centres, including 11 Part-time Therapeutic Reception Centres spread over 11 towns in the area.
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.
For more information on Deenova’s market-leading solutions, visit www.deenova.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230426005604/en/
Contact information
Christophe Jaffuel, c.jaffuel@deenova.com,
Martina Buccianti, m.buccianti@deenova.com, +39 0523 785311
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SUI Group Announces Completion of Existing $2 Million Stock Repurchase Program and Subsequent Authorization of New $50 Million Program12.9.2025 23:05:00 EEST | Press release
SUI Group Holdings Limited (“SUI Group,” “SUIG” or the “Company”) (NASDAQ: SUIG), the only publicly traded company with an official relationship with the Sui Foundation, today announced it has completed its previously authorized $2 million stock repurchase program. SUI Group is also announcing that its Board of Directors has now authorized a new stock repurchase program to acquire up to an additional $50 million of the Company’s common stock. Following the completion of its initial stock repurchase program, in which the Company repurchased approximately 318,743 shares of its common stock at an average price of $4.30 per share between September 10, 2025 and September 12, 2025, SUI Group’s new program provides the flexibility to support its Net Asset Value (“NAV”) per share by opportunistically purchasing its common stock. The Company believes that share repurchases at these levels are immediately accretive to existing stockholders and reflects its confidence in its underlying fundamenta
Allied Nations Gather to Discuss Future of Multilateral Defence Security Financing12.9.2025 18:35:00 EEST | Press release
The Defence, Security and Resilience Bank (DSRB) Development Group co-hosted an international conference in the City of London this week to discuss the creation of a new multilateral bank designed to bring capital market expertise to the frontlines of global security. The event at Mansion House, co-hosted by the Lord Mayor of London, included 72 attendees from 37 countries across the NATO alliance, the EU, and Indo-Pacific allied nations. Held on the eve of the Defence and Security Equipment International (DSEI event), the DSRB “Information Day” event also included a further 88 attendees from a wide range of institutions including the European Union, NATO, eight partner commercial banks, multiple development and central banks as well as representatives from global funds, ratings agencies, industry associations and think tanks. Notes to Editors: The DSR Bank Development Group is a non-profit working toward the establishment of the full bank alongside nation states and institutions. The
Illumination and Nintendo Announce the New Animated Film Based on the World of Super Mario Bros. Will Be Titled The Super Mario Galaxy Movie12.9.2025 16:33:00 EEST | Press release
Illumination (HQ: Santa Monica, CA, USA; Founder and CEO: Chris Meledandri) and Nintendo Co., Ltd. (HQ: Kyoto, Minami-ku, Japan; Representative Director and President: Shuntaro Furukawa, “Nintendo” hereafter) today announced that the title of the new animated film based on the world of Super Mario Bros., will be The Super Mario Galaxy Movie. The film will be released worldwide by Universal Pictures beginning April 3, 2026. In addition, the two companies announced that the returning voice actors for the characters will be: Mario (Chris Pratt), Princess Peach (Anya Taylor-Joy), Luigi (Charlie Day), Bowser (Jack Black), Toad (Keegan-Michael Key), and Kamek (Kevin Michael Richardson). The additional characters and voice cast for The Super Mario Galaxy Movie will be announced at a later date. The Super Mario Galaxy Movie will be released on April 3, 2026 in the US and many additional markets globally, and will be released on April 24, 2026 in Japan, with select territories releasing through
TON Strategy Company Announces Initial Share Repurchases Under $250 Million Program, Buying Below Treasury Asset Value Per Share, and Start of Staking12.9.2025 15:30:00 EEST | Press release
TON Strategy Company (Nasdaq: TONX) (the “Company”), a digital asset treasury company committed to holding Toncoin ($TON), today announced that it has repurchased over 250,000 shares of its common stock under its previously announced $250 million share repurchase program. Further, the Company has started staking operations, as planned, to generate on-chain income by utilizing its treasury holdings. The Company repurchased shares at an average of $8.32 per share; by comparison, the Company’s TAV per share was $12.181 as of September 11, 2025. This week’s share repurchases and the start of staking underscore TON Strategy Company’s financial strength, commitment to shareholder value, and long-term confidence in The Open Network (TON) ecosystem. They coincide with recent milestones in the broader TON network – including the availability of $TON on Gemini, Robinhood, and Zengo – which the Company believes represent steps toward broader market access for the token as the native asset of TON,
Ant Group’s AI Healthcare App AQ Users Reach 140 Million, 60% from Tier-three and Lower-Tier Cities12.9.2025 14:38:00 EEST | Press release
At the 2025 INCLUSION · Conference on the Bund in Shanghai, Ant Group’s AI-powered healthcare app AQ has rolled out a new suite of service updates aimed at making healthcare more inclusive and accessible. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250912715926/en/ Ant Group’s AI healthcare app supports users’ daily health needs, extending doctors’ reach beyond time and space. “We hope AI can empower doctors by extending their reach to more patients, freeing up time for medical research and the fight against complex diseases, while equipping community doctors with powerful AI assistants,” said Cyril Han, CEO of Ant Group. Since AQ’s official launch in China in June 2025, following public testing that began in September 2024, the app has served 140 million users, with 60% coming from third-tier cities and below. It offers more than 100 AI-powered services to support users in their daily healthcare needs, including doctor r
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom